Hepatitis B virus (HBV) care cascade characterisation is important for monitoring HBV
elimination progress. This study evaluated care cascade and factors associated with HBV …

The Australian National Hepatitis B Strategy 2010–13 outlines five priority areas for
developing a comprehensive response to the hepatitis B virus (HBV): building partnerships …

Background Chronic hepatitis B (CHB) is endemic in the Aboriginal population of Australia's
Northern Territory (NT). However, many people's hepatitis B virus (HBV) status remains …

Background: Published Canadian epidemiologic data on hepatitis B virus (HBV) infection
include single-centre studies or are focused on Indigenous populations. We performed a …

Background Liver disease and hepatocellular carcinoma (HCC) are important contributors to
the mortality gap between Indigenous and non-Indigenous Australians. However, there is a …

Objective: To estimate the level of access to diagnosis, management and treatment for
people living with chronic hepatitis B (CHB) in Australia, and to identify the gaps in clinical …

Background Chronic hepatitis B infection is endemic in New Zealand and has high
prevalence in New Zealand Māori. Previous longitudinal studies in populations with …

There is little recent data of the seroprevalence of hepatitis B in Australia. We have surveyed
a large cohort of endoscopy patients attending a teaching hospital in central Sydney, and …

Abstract Background Chronic hepatitis B (CHB) is one of the leading causes of liver cirrhosis
and liver cancer globally. In Australia, Aboriginal and Torres Strait Islander people of the …

Approximately 80 million people live with chronic hepatitis B virus (HBV) infection in the
WHO Africa Region. The natural history of HBV infection in this population is poorly …